Ufp Technologies (UFPT) Change in Account Payables (2010 - 2026)
Ufp Technologies (UFPT) posted Change in Account Payables of $3.9 million for Q1 2026, up 174.03% on a QoQ basis from -$5.3 million in Q4 2025, and down 25.64% year-over-year from $5.3 million in Q1 2025.
Ufp Technologies (UFPT) Change in Account Payables (2010 - 2026) Analysis & Trends
Ufp Technologies' Change in Account Payables history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- Quarterly Change in Account Payables fell 25.64% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 190.09% YoY) and the FY2025 annual result came in at -$1.1 million, up 4.55% from the prior year.
- Change in Account Payables was $3.9 million for Q1 2026 at Ufp Technologies, up from -$5.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.7 million in Q2 2022 and bottomed at -$7.6 million in Q2 2025.
- A 5-year average of $728294.1 and a median of $1.4 million in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 18083.33% in 2025, while the deepest fall reached 945.74% in 2025.
- Ufp Technologies' Change in Account Payables stood at $2.8 million in 2022, then plunged by 284.55% to -$5.2 million in 2023, then surged by 63.62% to -$1.9 million in 2024, then slumped by 182.59% to -$5.3 million in 2025, then soared by 174.03% to $3.9 million in 2026.
- Business Quant data shows UFPT's Change in Account Payables at $3.9 million in Q1 2026, -$5.3 million in Q4 2025, and $6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | -5.31 Mn |
| Dec 31, 2025 | -5.31 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Jun 30, 2025 | -7.61 Mn |
| Jun 30, 2025 | -7.61 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -728,000.00 |
| Jun 30, 2024 | -728,000.00 |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | -5.16 Mn |
| Dec 31, 2023 | -5.16 Mn |